Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF).

Whether encouraging people with cystic fibrosis to do more vigorous exercise actually protects their lung function over time has been unclear, so this trial compared a 12-month partially supervised activity programme against usual activity levels in people who started out relatively inactive. The intervention group was asked to add three hours of vigorous activity per week, while the control group was asked to keep their activity unchanged. After 6 months, the group that did not increase activity showed a statistically significantly greater improvement in a measure of lung function (FEV1) than the exercise group, the opposite of what researchers expected. The exercise group did do more vigorous activity and had better exercise capacity, effects that carried into the following months.

Other outcomes, including exacerbations, quality of life and mood measures, showed no clear differences. The trial recruited only 40% of its planned sample, which limits confidence in these findings.

If you or someone you know has cystic fibrosis, you may have heard that more exercise is generally good for lung health. This study tested that idea directly by asking one group of people with cystic fibrosis to add three hours of vigorous exercise each week for a year, while another group kept their usual activity level. Surprisingly, the group that kept their activity unchanged showed a bigger improvement in a key lung function test after six months than the group that exercised more.

The exercise group did become fitter and more active, and these gains lasted into the following months, but this didn't translate into better lung function. Other things researchers measured, like how often people had flare-ups, quality of life, and mood, didn't differ clearly between groups.

This was a fairly small study that didn't reach its planned number of participants, so these results shouldn't be taken as the final word on whether exercise programmes help or don't help lung function in cystic fibrosis.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This trial addresses a question that shapes exercise counselling in cystic fibrosis care: does structured, partially supervised vigorous physical activity preserve or improve lung function over time in people who are otherwise relatively inactive? The ACTIVATE-CF randomised controlled trial compared an intervention group, asked to add three hours of vigorous activity weekly with motivational feedback, against a control group asked not to change their activity, across 12 months. The primary outcome, change in percent predicted FEV1 at 6 months, was significantly higher in the control group than the intervention group (difference 2.70% predicted, 95% CI 0.13 to 5.26, P=0.04), a result opposite to the trial's hypothesis. Secondary outcomes showed the intervention group achieved and sustained higher physical activity and higher exercise capacity through 12 months, but no significant between-group effects emerged for exacerbation timing or rate, quality of life, anxiety, depression, stress, or glucose control.

This dissociation between improved fitness/activity and lung function outcomes is worth noting when counselling patients, since it suggests increased vigorous activity alone did not translate into better spirometry in this cohort. The trial enrolled only 117 of its planned sample, reaching roughly 40% of target recruitment, which limits statistical confidence and the precision of both the primary and secondary findings. The abstract does not report adverse events, so no safety conclusions can be drawn, and the single statistically significant outcome favouring controls should be interpreted cautiously given the trial's reduced size.